Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

Research In Brief

This article was originally published in The Gray Sheet

  • News

Executive Summary

Assessing early AF intervention

You may also be interested in...



People In Brief

Top post appointments at STAT-Diagnostica, Histogenics and Mindray. More personnel news.

Financings In Brief

InspireMD plans stock offering to raise up to $46 million for stent system. Torax gets $30 mil. for GERD treatment. BioFire Diagnostics raises $25 mil. for FilmArray platform. More financings.

Diabetes Experts Explore Pros And Cons Of Developing Mobile Health Apps

Mobile health developers looking to enter the diabetes care space face significant challenges, but also have a unique opportunity to address critical user needs, experts said recently.

Table

View full table

Topics

Tags:
Medical Device
Latest Headlines

EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions

UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children

See All
UsernamePublicRestriction

Register

MT030425

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By